The role of dopamine in methylene blue-mediated inhibition of estradiol benzoate-induced anterior pituitary hyperplasia in rats
- PMID: 11343835
- DOI: 10.1016/s0304-3940(01)01752-9
The role of dopamine in methylene blue-mediated inhibition of estradiol benzoate-induced anterior pituitary hyperplasia in rats
Abstract
Recently, we demonstrated that methylene blue partially inhibited estradiol-benzoate-induced anterior pituitary hyperplasia in rats. Since central dopaminergic systems participate in the regulation of estrogen-induced anterior pituitary growth and tumor transformation, this study examined whether a 3-week treatment with methylene blue could affect anterior pituitary levels of dopamine (DA), dihydroxyphenylalanine (DOPA), and dihydroxyphenylacetic acid and dopamine (D-2) receptors in male rats. Compared to controls, methylene blue significantly decreased anterior pituitary weight, increased basal anterior pituitary DA levels, and inhibited estradiol benzoate-induced decreases in anterior pituitary DA concentrations. Furthermore, we found that methylene blue alone decreased anterior pituitary D-2 receptor number. Methylene blue given in combination with estradiol benzoate partially inhibited estradiol benzoate-induced anterior pituitary growth and estradiol benzoate-induced increases in D-2 receptor number. Estradiol benzoate-treated rats had significantly lower anterior pituitary DOPA accumulation after intraperitoneal administration of 3,4-hydroxybenzyl-hydrazine dihydrochloride (NSD-1015), an irreversible inhibitor of L-aromatic amino acid decarboxylase whereas methylene blue did not affect anterior pituitary DOPA accumulation when compared to controls. Methylene blue decreased anterior pituitary prolactin levels and inhibited increases in anterior pituitary prolactin after estradiol benzoate administration. The present results suggest that anterior pituitary DA may play an important role in estrogen-induced anterior pituitary hyperplasia and tumor formation and that antioxidant drugs such as methylene blue may attenuate estrogen-induced pituitary growth. This may occur via increases in anterior pituitary DA levels associated with down-regulation of anterior pituitary D-2 receptors.
Similar articles
-
The regulation of adenohypophyseal prolactin secretion: effect of triiodothyronine and methylene blue on estrogenized rat adenohypophysis.Physiol Res. 2000;49 Suppl 1:S27-35. Physiol Res. 2000. PMID: 10984069 Review.
-
Anterior pituitary weight, cAMP, cGMP and prolactin levels after combined treatment with estradiol and methylene blue.Physiol Res. 1993;42(3):171-4. Physiol Res. 1993. PMID: 8218149
-
Anterior pituitary weight, cAMP, cGMP and prolactin levels after combined treatment with estradiol and methylene blue.Physiol Res. 1993;42(6):171-4. Physiol Res. 1993. PMID: 8180149
-
Triiodothyronine attenuates estradiol-induced increases in dopamine D-2 receptor number in rat anterior pituitary.Brain Res. 1996 Mar 11;712(1):148-52. doi: 10.1016/0006-8993(95)01524-8. Brain Res. 1996. PMID: 8705298
-
Adenohypophyseal ascorbic acid: influences of oestradiol and methylene blue.Physiol Res. 1995;44(5):333-5. Physiol Res. 1995. PMID: 8869269
Cited by
-
Evaluation of the protein biomarkers and the analgesic response to systemic methylene blue in patients with refractory neuropathic pain: a double-blind, controlled study.J Pain Res. 2015 Jul 15;8:387-97. doi: 10.2147/JPR.S84685. eCollection 2015. J Pain Res. 2015. PMID: 26213475 Free PMC article.
-
Cellular and molecular actions of Methylene Blue in the nervous system.Med Res Rev. 2011 Jan;31(1):93-117. doi: 10.1002/med.20177. Med Res Rev. 2011. PMID: 19760660 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources